Nonsteroidal Anti-Inflammatory Drugs and the Kidney

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Bombardier, C., Laine, L., Reicin, A. S., Shapiro, D., Burgos‐Vargas, R., Davis, B. R., Day, R. O., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,014 · see citing works

Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis

Silverstein, F. E., Faich, G. A., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G. M., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,144 · see citing works

Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

Solomon, S. D., McMurray, J. J. V., Pfeffer, M. A., Wittes, J. T., Fowler, R. A., Finn, P. V., Anderson, W. F., Zauber, A. G., Hawk, E. T., & Bertagnolli, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050405 · Cited by 2,046 · see citing works

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration

Langenbach, R. J., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,120 · see citing works

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse

Morham, S. G., Langenbach, R. J., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,080 · see citing works

Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II

Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., JAFFEE, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al. (1995) · Nature · doi:10.1038/378406a0 · Cited by 967 · see citing works

Cardiovascular death in rheumatoid arthritis: A population‐based study

Kremers, H. M., Nicola, P., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20878 · Cited by 934 · see citing works

Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction.

Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., DuBois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 856 · see citing works

Renal Failure in Cirrhosis

Ginès, P., & Schrier, R. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0809139 · Cited by 836 · see citing works

Evolution of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Cyclooxygenase (COX) Inhibition and Beyond

Rao, P. P. N., & Knaus, E. E. (2008) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3t886 · Cited by 776 · see citing works

Cyclooxygenase‐independent actions of cyclooxygenase inhibitors

Tegeder, I., Pfeilschifter, J. M., & Geißlinger, G. (2001) · The FASEB Journal · doi:10.1096/fj.01-0390rev · Cited by 748 · see citing works

Paracrine regulation of the renal microcirculation

Navar, L. G., Inscho, E. W., Majid, S. A., Imig, J. D., Harrison‐Bernard, L. M., & Mitchell, K. D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.425 · Cited by 737 · see citing works

Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis

Johnson, A. G., Nguyen, T. V., & Day, R. O. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00011 · Cited by 717 · see citing works

Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney.

Nielsen, S. D.-H., DiGiovanni, S. R., Christensen, E., Knepper, M. A., & Harris, H. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11663 · Cited by 711 · see citing works

Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications

Whelton, A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00113-8 · Cited by 704 · see citing works

Ibuprofen: pharmacology, efficacy and safety

Rainsford, K. D. (2009) · Inflammopharmacology · doi:10.1007/s10787-009-0016-x · Cited by 671 · see citing works

Membrane Prostaglandin E Synthase-1: A Novel Therapeutic Target

Samuelsson, B. O., Morgenstern, R., & Jakobsson, P. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.3.1 · Cited by 537 · see citing works

A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure

Pope, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040045007 · Cited by 527 · see citing works

COX-2 and beyond: approaches to prostaglandin inhibition in human disease

FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518 · see citing works

Epidemiology of NSAID induced gastrointestinal complications.

Singh, G., & Triadafilopoulos, G. (1999) · PubMed · Cited by 493 · see citing works

The risk of congestive heart failure in rheumatoid arthritis: A population‐based study over 46 years

Nicola, P., Kremers, H. M., Roger, V. L., Jacobsen, S. J., Crowson, C. S., Ballman, K. V., & Gabriel, S. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20855 · Cited by 484 · see citing works

Risk of Kidney Failure Associated with the Use of Acetaminophen, Aspirin, and Nonsteroidal Antiinflammatory Drugs

Perneger, T. V., Whelton, P. K., & Klag, M. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412223312502 · Cited by 484 · see citing works

Nonsteroidal Anti-Inflammatory Drugs: Adverse Effects and Their Prevention

Vonkeman, H. E., & van de Laar, M. A. F. J. (2008) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.08.001 · Cited by 370 · see citing works

Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function

Kömhoff, M., Gröne, H., Klein, T., Seyberth, H. W., & Nüsing, R. M. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.4.f460 · Cited by 365 · see citing works

Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function

Cheng, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27540 · Cited by 339 · see citing works

Effect of Cyclooxygenase-2 Inhibition on Renal Function in Elderly Persons Receiving a Low-Salt Diet

Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 336 · see citing works

Resistant Hypertension

Sarafidis, P. A., & Bakris, G. L. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.036 · Cited by 333 · see citing works

NSAID Use and Progression of Chronic Kidney Disease

Gooch, K. L., Culleton, B. F., Manns, B., Zhang, J., Alfonso, H. S., Tonelli, M. A., Frank, C., Klarenbach, S. W., & Hemmelgarn, B. R. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.015 · Cited by 333 · see citing works

Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events

Zhang, J., Ding, E. L., & Song, Y. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60015 · Cited by 332 · see citing works

Cyclooxygenase-2???Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients

Whelton, A., Fort, J. G., Puma, J. A., Normandin, D. E., Bello, A. E., & Verburg, K. M. (2001) · American Journal of Therapeutics · doi:10.1097/00045391-200103000-00003 · Cited by 332 · see citing works

Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure

(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.ioi50013 · Cited by 329 · see citing works

Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects

Rossat, J., Maillard, M. P., Nussberger, J., Brünner, H., & Burnier, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 316 · see citing works

Effects of celecoxib and rofecoxib on blood pressure and edema in patients ≥65 years of age with systemic hypertension and osteoarthritis

Whelton, A., White, W. B., Bello, A. E., Puma, J. A., & Fort, J. G. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02661-9 · Cited by 310 · see citing works

Acetaminophen, Aspirin, and Chronic Renal Failure

Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C., Blot, W. J., McLaughlin, J. K., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010323 · Cited by 289 · see citing works

Prostaglandins: Modulators of Renal Function and Pressor Resistance in Chronic Liver Disease*

Zipser, R. D., Hoefs, J. C., Speckart, P., ZIA, P. K., & Horton, R. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-6-895 · Cited by 288 · see citing works

Effects of Celecoxib and Naproxen on Renal Function in the Elderly

Whelton, A., Schulman, G., Wallemark, C. B., Drower, E. J., Isakson, P. C., Verburg, K. M., & Geis, G. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1465 · Cited by 279 · see citing works

Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.

BOYER, T. D., ZIA, P. K., & Reynolds, T. B. (1979) · PubMed · Cited by 276 · see citing works

Nonsteroidal Antiinflammatory Drugs and Acute Renal Failure in Elderly Persons

Griffin, M. R., Yared, A., & Ray, W. A. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010234 · Cited by 271 · see citing works

Renal Effects of COX-2-Selective Inhibitors

Brater, D. C., Harris, C. J., Redfern, J. S., & Gertz, B. J. (2001) · American Journal of Nephrology · doi:10.1159/000046212 · Cited by 263 · see citing works

Renal adverse effects of nonsteroidal anti-inflammatory drugs

Harirforoosh, S., & Jamali, F. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903311023 · Cited by 260 · see citing works

Analgesic Use and Chronic Renal Disease

Sandler, D. P., Smith, J. C., Weinberg, C. R., Buckalew, V. M., Dennis, V. W., Blythe, W. B., & Burgess, W. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198905113201903 · Cited by 254 · see citing works

Effect of indomethacin and prostaglandin A, on renal function and plasma renin activity in alcoholic liver disease

BOYER, T. D., ZIA, P. K., & Reynolds, T. B. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90268-3 · Cited by 252 · see citing works

Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II

Qi, Z., Hao, C., Langenbach, R. I., BREYER, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14752 · Cited by 249 · see citing works

Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide

Hwang, D. H., Jang, B. C., Yu, G., & Boudreau, M. D. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00154-8 · Cited by 248 · see citing works

Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase -2–selective inhibition

Brater, D. C. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00369-1 · Cited by 244 · see citing works

Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function

Carmichael, J., & Shankel, S. W. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90223-2 · Cited by 234 · see citing works

The Effects of Cyclooxygenase-2 Inhibitors and Nonsteroidal Anti-inflammatory Therapy on 24-Hour Blood Pressure in Patients With Hypertension, Osteoarthritis, and Type 2 Diabetes Mellitus

Sowers, J. R., White, W. B., Pitt, B., Whelton, A., Simon, L. S., Winer, N., Kivitz, A., van Ingen, H., Brabant, T., Fort, J. G., et al. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.2.161 · Cited by 233 · see citing works

Juxtaglomerular cell complex in the regulation of renal salt excretion

Schnermann, J. B. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.2.r263 · Cited by 232 · see citing works

Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function.

Yarger, W., Schocken, D. D., & Harris, R. H. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109683 · Cited by 224 · see citing works

Adverse renal effects of anti‐inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors

Gambaro, G., & Perazella, M. A. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01146.x · Cited by 223 · see citing works

Nonsteroidal Anti-inflammatory Drugs and the Risk for Chronic Renal Disease

Sandler, D. P., Burr, F. R., & Weinberg, C. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-3-165 · Cited by 213 · see citing works

Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion

Arroyo, V., Planas, R., Gaya, J., Deulofeu, R., Rimola, A., PÉREZ‐AYUSO, O. M., Rivera, F., & Rodés, J. (1983) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1983.tb00100.x · Cited by 212 · see citing works

Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II

Qi, Z., Hao, C., Langenbach, R. I., BREYER, R. M., Redha, R., Morrow, J. D., & Breyer, M. D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214752 · Cited by 208 · see citing works

Interspecies Differences in Renal Localization of Cyclooxygenase Isoforms: Implications in Nonsteroidal Antiinflammatory Drug-Related Nephrotoxicity

Khan, K. N. M., Venturini, C. M., Bunch, R. T., Brassard, J. A., Koki, A. T., Morris, D. L., Trump, B. E., Maziasz, T. J., & Alden, C. L. (1998) · Toxicologic Pathology · doi:10.1177/019262339802600504 · Cited by 201 · see citing works

Cytokine-induced production of monocyte chemoattractant protein-1 by cultured human mesangial cells

Rovin, B. H., Yoshiumura, T., & Tan, L. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2148 · Cited by 200 · see citing works

Angiotensin II attenuates renal cortical cyclooxygenase-2 expression

Cheng, H., Wang, J.-L., Zhang, M., Miyazaki, Y., Ichikawa, I., McKanna, J. A., & Harris, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5505 · Cited by 199 · see citing works

Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis

Diamond, J. R., Kees‐Folts, D., Ding, G., Frye, J., & Restrepo, N. C. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.6.f926 · Cited by 197 · see citing works

Cyclooxygenase-2 inhibitor blocks expression of mediators of renal injury in a model of diabetes and hypertension1

Cheng, H., Wang, C. J., Moeckel, G. W., Zhang, M., McKanna, J. A., & Harris, R. C. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00520.x · Cited by 192 · see citing works

Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis.

Rovin, B. H., Rumancik, M., Tan, L., & Dickerson, J. (1994) · PubMed · Cited by 188 · see citing works

Acknowledgment of Reviewers

Kömhoff, M., Wang, J. L., Cheng, H. F., Langenbach, R., McKanna, J. A., Harris, R. C., & Breyer, M. D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00861.x · Cited by 187 · see citing works

Immunohistochemical and functional correlations of renal cyclooxygenase-2 in experimental diabetes

Komers, R., Lindsley, J. N., Oyama, T., Schutzer, W. E., Reed, J. F., Mader, S. L., & Anderson, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10228 · Cited by 187 · see citing works

Clinical use and pharmacological properties of selective COX-2 inhibitors

Shi, S., & Klotz, U. E. (2007) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-007-0400-7 · Cited by 180 · see citing works

Drug combinations and impaired renal function – the ‘triple whammy’

Loboz, K. K., & Shenfield, G. M. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.0306-5251.2004.2188.x · Cited by 179 · see citing works

Cyclooxygenase-2 Mediates Increased Renal Renin Content Induced by Low-Sodium Diet

Harding, P., Sigmon, D. H., Alfie, M. E., Huang, P. L., Fishman, M. C., Beierwaltes, W. H., & Carretero, O. A. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.297 · Cited by 175 · see citing works

Cyclooxygenase-2 Inhibition Decreases Renin Content and Lowers Blood Pressure in a Model of Renovascular Hypertension

Wang, J., Cheng, H., & Harris, R. C. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.96 · Cited by 175 · see citing works

Are selective COX-2 inhibitors nephrotoxic?

Perazella, M. A., & Eras, J. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70266-6 · Cited by 173 · see citing works

COX-2 selectivity alone does not define the cardiovascular risks associated with non-steroidal anti-inflammatory drugs

Warner, T. D., & Mitchell, J. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60137-3 · Cited by 166 · cited 1× · see citing works

Lifetime Nonnarcotic Analgesic Use and Decline in Renal Function in Women

Curhan, G. C., Knight, E. L., ROSNER, B. A., Hankinson, S. E., & Stampfer, M. J. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.14.1519 · Cited by 165 · see citing works

Cyclooxygenase-2–selective inhibitors impair glomerulogenesis and renal cortical development

Kömhoff, M., Wang, J., Cheng, H., Langenbach, R. I., McKanna, J. A., Harris, R. C., & Breyer, M. D. (2000) · Kidney International · doi:10.1016/s0085-2538(15)46757-2 · Cited by 164 · see citing works

Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal‐salt diet

Schwartz, J. I., Vandormael, K., Malice, M., Kalyani, R. N., Lasseter, K. C., Holmes, G. B., Gertz, B. J., Gottesdiener, K. M., Laurenzi, M. W., Redfern, K. ‐., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126182 · Cited by 161 · see citing works

Diuretics, ACE inhibitors and NSAIDs — the triple whammy

Thomas, M. C. (2000) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2000.tb125548.x · Cited by 159 · see citing works

MF63 [2-(6-Chloro-1 H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a Selective Microsomal Prostaglandin E Synthase-1 Inhibitor, Relieves Pyresis and Pain in Preclinical Models of Inflammation

Xu, D., Rowland, S. E., Clark, P., Giroux, A., Côté, B., Guiral, S., Salem, M., Ducharme, Y., Friesen, R. W., Méthot, N., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138776 · Cited by 157 · see citing works

A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats

Wang, J.-L., Cheng, H.-F., Shappell, S. B., & Harris, R. C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00093.x · Cited by 155 · see citing works

Low Chloride Stimulation of Prostaglandin E2Release and Cyclooxygenase-2 Expression in a Mouse Macula Densa Cell Line

Yang, T., Park, J. M., Arend, L. J., Huang, Y. G., Topaloğlu, R., Pasumarthy, A., Prætorius, H. A., Spring, K. R., Briggs, J. P., & Schnermann, J. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006218200 · Cited by 154 · see citing works

Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors

White, W. B., Kent, J. D., Taylor, A. A., Verburg, K. M., Lefkowith, J. B., & Whelton, A. (2002) · Hypertension · doi:10.1161/01.hyp.0000014323.99765.16 · Cited by 149 · see citing works

Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells

Peti‐Peterdi, J., Komlósi, P., Fuson, A. L., Guan, Y., Schneider, A., Qi, Z., Redha, R., Rosivall, L., Breyer, M. D., & Bell, P. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318018 · Cited by 149 · see citing works

NSAID prescribing precautions.

Risser, A. L., Donovan, D., Heintzman, J. D., & Page, T. (2009) · PubMed · Cited by 148 · see citing works

Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN-gamma, tumor necrosis factor-alpha, IgG aggregates, and cAMP in mouse mesangial cells

Satriano, J. A., Hora, K., Shan, Z., Stanley, E. R., Mori, T., & Schlöndorff, D. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1971 · Cited by 147 · see citing works

Role for Thromboxane Receptors in Angiotensin-II–Induced Hypertension

Francois, H., Athirakul, K., Mao, L., Rockman, H. A., & Coffman, T. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000112225.27560.24 · Cited by 144 · see citing works

Occupational and other exposures associated with male end-stage renal disease: a case/control study.

Steenland, N. K., Thun, M. J., Ferguson, C. W., & Port, F. K. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.2.153 · Cited by 142 · see citing works

Dehydration activates an NF-κB–driven, COX2-dependent survival mechanism in renal medullary interstitial cells

Hao, C., Yull, F. E., Blackwell, T. S., Kömhoff, M., Davis, L. S., & Breyer, M. D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9956 · Cited by 142 · see citing works

Ibuprofen Interferes with the Efficacy of Antihypertensive Drugs: A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Compared with Acetaminophen

RADACK, K. L., DECK, C. C., & BLOOMFIELD, S. S. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-5-628 · Cited by 140 · see citing works

COX-2 and the Kidney

Harris, R. C. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200605001-00007 · Cited by 139 · see citing works

Cyclooxygenase-2 in rat nephron development

Zhang, M., Wang, J., Cheng, H., Harris, R. C., & McKanna, J. A. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.6.f994 · Cited by 135 · see citing works

Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride

Cheng, H., Wang, J.-L., Zhang, M., McKanna, J. A., & Harris, R. C. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10318 · Cited by 132 · see citing works

Prevention, Incidence, and Outcomes of Contrast-Induced Acute Kidney Injury

Weisbord, S. D. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1325 · Cited by 127 · see citing works

Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis

Stahl, R. A. K., Thaiss, F., Disser, M., Helmchen, U. M., Hora, K., & Schlöndorff, D. (1993) · Kidney International · doi:10.1038/ki.1993.346 · Cited by 127 · see citing works

Inhibition of macula densa-stimulated renin secretion by pharmacological blockade of cyclooxygenase-2

Traynor, T. R., Smart, A., Briggs, J. P., & Schnermann, J. B. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.277.5.f706 · Cited by 126 · see citing works

NSAIDs and Increased Blood Pressure

Johnson, A. G. (1997) · Drug Safety · doi:10.2165/00002018-199717050-00001 · Cited by 122 · see citing works

Analgesic Use and Renal Function in Men

Rexrode, K. M. (2001) · JAMA · doi:10.1001/jama.286.3.315 · Cited by 122 · see citing works

Immunolocalization of cyclooxygenase‐2 in the macula densa of human elderly

Nantel, F., Meadows, E., Denis, D., Connolly, B., Metters, K. M., & Giaid, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01088-1 · Cited by 121 · see citing works

Renal effects of nonselective NSAIDs and coxibs.

Weir, M. R. (2002) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.69.suppl_1.si53 · Cited by 121 · see citing works

Selective and non‐selective non‐steroidal anti‐inflammatory drugs and the risk of acute kidney injury

Lafrance, J., & Miller, D. R. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1798 · Cited by 119 · see citing works

Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria

Rao, R., Zhang, M., Zhao, M., Cai, H., Harris, R. C., Breyer, M. D., & Hao, C. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00287.2004 · Cited by 119 · see citing works

Cyclooxygenase-2 in the Kidney

Harris, R. C. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11122387 · Cited by 114 · see citing works

Novel Nonsteroidal Antiinflammatory Drugs Possessing a Nitric Oxide Donor Diazen-1-ium-1,2-diolate Moiety: Design, Synthesis, Biological Evaluation, and Nitric Oxide Release Studies

Velázquez, C. A., Rao, P. P. N., & Knaus, E. E. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050211k · Cited by 111 · see citing works

Regular Analgesic Intake and the Risk of End-Stage Renal Failure

Pommer, W., Bronder, E., Greiser, E. M., Helmert, U., dagger, H. J. J., Klimpel, A., Borner, K., & Molzahn, M. (2008) · American Journal of Nephrology · doi:10.1159/000168002 · Cited by 111 · see citing works

Dexamethasone inhibits the induction of monocyte chemotactic-activating factor production by IL-1 or tumor necrosis factor

Mukaida, N., Zachariae, C. O. C., Gusella, G. L., & Matsushima, K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.4.1212 · Cited by 109 · see citing works

MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7 H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a Selective E Prostanoid Receptor 4 Antagonist, Relieves Joint Inflammation and Pain in Rodent Models of Rheumatoid and Osteoarthritis

Clark, P., Rowland, S. E., Denis, D., Mathieu, M., Stocco, R., Poirier, H., Burch, J. D., Han, Y., Audoly, L., Therien, A. G., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134510 · Cited by 105 · see citing works

COX-2 inhibition prevents downregulation of key renal water and sodium transport proteins in response to bilateral ureteral obstruction

Nørregaard, R., Jensen, B. L., Li, C., Wang, W., Knepper, M. A., Nielsen, S. M., & Frøkiær, J. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00061.2005 · Cited by 105 · see citing works

Genetic deletion of COX-2 prevents increased renin expression in response to ACE inhibition

Cheng, H., Wang, J., Zhang, M., Wang, S., McKanna, J. A., & Harris, R. C. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.3.f449 · Cited by 100 · see citing works

End‐stage renal disease and non‐narcotic analgesics: a case‐control study.

Morlans, M., Laporte, J., Vidal, X., CABEZA, D., & Pd, S. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03841.x · Cited by 99 · see citing works

Monocyte chemoattractant protein-1 in normal and diseased human kidneys: an immunohistochemical analysis.

Prodjosudjadi, W., Gerritsma, J. S. J., van Es, L. A., Daha, M. R., & Bruijn, J. A. (1995) · PubMed · Cited by 98 · see citing works

Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis.

Tomasoni, S., Noris, M., Zappella, S., Gotti, E., Casiraghi, F., Bonazzola, S., Benigni, A., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971202 · Cited by 95 · see citing works

Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man.

Chennavasin, P., Seiwell, R., & Brater, D. C. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32257-3 · Cited by 94 · see citing works

Epidemiologic Study of Regular Analgesic Use and End-Stage Renal Disease

Murray, T. G. (1983) · Archives of Internal Medicine · doi:10.1001/archinte.1983.00350090053009 · Cited by 93 · see citing works

Inhibition of the Renin-Angiotensin System Upregulates Cyclooxygenase-2 Expression in the Macula Densa

Wolf, K., Castrop, H., Hartner, A., Goppelt‐Strübe, M., Hilgers, K. F., & Kurtz, A. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.503 · Cited by 93 · see citing works

The Effect of Cyclooxygenase-2 Inhibition on Renal Hemodynamic Function in Humans With Type 1 Diabetes

Cherney, D. Z. I., Miller, J., Scholey, J. W., Bradley, T. J., Slorach, C., Curtis, J. R., Dekker, M. G., Nasrallah, R., Hébert, R., & Sochett, E. B. (2007) · Diabetes · doi:10.2337/db07-1230 · Cited by 90 · see citing works

Cyclooxygenase-2 participates in tubular flow-dependent afferent arteriolar tone: interaction with neuronal NOS

Ichihara, A., Imig, J. D., Inscho, E. W., & Navar, L. G. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.4.f605 · Cited by 90 · see citing works

Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans

Schwartz, J. I., CHAN, C., Mukhopadhyay, S., MCBRIDE, K., JONES, T., Adcock, S., MORITZ, C., Hedges, J. R., Grasing, K., & DOBRATZ, D. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)90087-5 · Cited by 89 · see citing works

Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites†

Clària, J., Kent, J. D., López‐Parra, M., Escolar, G., Ruíz-del-Árbol, L., Ginès, P., Jiménez, W., Vucelic, B. N., & Arroyo, V. (2005) · Hepatology · doi:10.1002/hep.20595 · Cited by 89 · see citing works

Renal complications associated with use of nonsteroidal anti-inflammatory agents.

Palmer, B. F. (1995) · PubMed · Cited by 89 · see citing works

Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Vascular Smooth Muscle Ion Channels May Account for Differences in Cardiovascular Risk Profiles

Brueggemann, L. I., Mackie, A. R., Mani, B. K., Cribbs, L. L., & Byron, K. L. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.057844 · Cited by 86 · see citing works

Nonsteroidal Anti-Inflammatory Drugs and Hypertension

de Leeuw, P. W. (1996) · Drugs · doi:10.2165/00003495-199651020-00001 · Cited by 85 · see citing works

Cyclo‐oxygenase‐2 inhibition increases blood pressure in rats

Höcherl, K., Endemann, D., Kammerl, M., Grobecker, H., & Kurtz, A. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704821 · Cited by 83 · see citing works

Nonsteroidal antiinflammatory drugs: Past, present and future☆

Patrono, C., & Rocca, B. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.01.011 · Cited by 83 · see citing works

Effect of Inhibitors of Prostaglandin Synthesis on Induced Diuresis in Cirrhosis

Mirouze, D., Zipser, R. D., & Reynolds, T. B. (1983) · Hepatology · doi:10.1002/hep.1840030108 · Cited by 83 · see citing works

Treatment of the Nephrotic Syndrome with Indomethacin

Donker, A. J. M., Brentjens, J. R., van der Hem, G. K., & Arisz, L. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000181478 · Cited by 83 · see citing works

Clinical pharmacology of etoricoxib: a novel selective COX-2 inhibitor

Patrignani, P., Capone, M. L., & Tacconelli, S. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.2.265 · Cited by 82 · see citing works

Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials

Curtis, S., Ng, J., Yu, Q., Shingo, S., Bergman, G., McCormick, C. L., & Reicin, A. S. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90007-0 · Cited by 81 · see citing works

The Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressures of Patients With Hypertension Controlled by Verapamil

Houston, M. C. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430100075009 · Cited by 78 · see citing works

The Effect of Nonsteroidal Anti‐Inflammatory Drugs on Blood Pressure in Patients Treated With Different Antihypertensive Drugs

Morgan, T. O., & Anderson, A. I. E. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.00514.x · Cited by 77 · see citing works

The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents

Armstrong, E. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90003-8 · Cited by 76 · see citing works

Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis

Ros, J., Clària, J., Jiménez, W., Bosch‐Marcé, M., Angeli, P., Arroyo, V., Rivera, F., & Rodés, J. (1995) · Hepatology · doi:10.1002/hep.1840220332 · Cited by 73 · see citing works

The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.

Perico, N., Remuzzi, A., Sangalli, F., Azzollini, N., Mister, M., Ruggenenti, P. L., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9122308 · Cited by 73 · see citing works

New Developments on Thromboxane and Prostacyclin Modulators Part II: Prostacyclin Modulators

de Leval, X., Hanson, J., David, J., Masereel, B., Pirotte, B., & Dogné, J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365279 · Cited by 73 · see citing works

Nitric oxide and prostaglandins are involved in the macula densa control of the renin system

Schricker, K., Hamann, M., & Kurtz, A. (1995) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1995.269.6.f825 · Cited by 73 · see citing works

Renal Hyperfiltration Is a Determinant of Endothelial Function Responses to Cyclooxygenase 2 Inhibition in Type 1 Diabetes

Cherney, D. Z. I., Miller, J., Scholey, J. W., Nasrallah, R., Hébert, R., Dekker, M. G., Slorach, C., Sochett, E. B., & Bradley, T. J. (2010) · Diabetes Care · doi:10.2337/dc09-2340 · Cited by 72 · see citing works

Cyclosporine A Suppresses Cyclooxygenase-2 Expression in the Rat Kidney

Höcherl, K., Dreher, F., Vitzthum, H., Diaeresis]hler, J. K., & Kurtz, A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031702.86799.b9 · Cited by 71 · see citing works

Nephrotoxicity in the Elderly Due to Co-Prescription of Angiotensin Converting Enzyme Inhibitors and Nonsteroidal Anti-Inflammatory Drugs

Adhiyaman, V., Asghar, M., Oke, A., White, A. D., & Shah, I. U. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401005 · Cited by 71 · see citing works

Sulindac Reduces the Urinary Excretion of Prostaglandins and Impairs Renal Function in Cirrhosis with Ascites

Quintero, E., Ginès, P., Arroyo, V., Rimola, A., Camps, J., Gaya, J., Guevara, A., Rodamilans, M., & Rodés, J. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000183692 · Cited by 70 · see citing works

Angiotensin II mediates downregulation of aquaporin water channels and key renal sodium transporters in response to urinary tract obstruction

Jensen, A. M., Li, C., Prætorius, H. A., Nørregaard, R., Frische, S., Knepper, M. A., Nielsen, S. M., & Frøkiær, J. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00387.2005 · Cited by 69 · see citing works

Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis

Wallace, J. L., Viappiani, S., & Bolla, M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.001 · Cited by 68 · see citing works

Indomethacin in the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus

Allen, H. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390050095019 · Cited by 68 · see citing works

Selective COX-2 Inhibitors

Vane, J. R., & Botting, J. H. (1998) · Springer eBooks · doi:10.1007/978-94-011-4872-6 · Cited by 66 · see citing works

Effect of prostaglandin E on immune complex nephritis in NZB/W mice.

Kelley, V. E., Winkelstein, A., & Izui, S. (1979) · PubMed · Cited by 65 · see citing works

Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction

Pimentel, J. L., Montero, Á., Wang, S., Yosipiv, I. V., El-Dahr, S. S., & Martínez–Maldonado, M. (1995) · Kidney International · doi:10.1038/ki.1995.408 · Cited by 65 · see citing works

Over-the-Counter Analgesic Use

Broe, M. E. D., & Elseviers, M. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101097 · Cited by 64 · see citing works

Inhibition of COX-2 counteracts the effects of diuretics in rats

Kammerl, M., Nüsing, R. M., Richthammer, W., Krämer, B. K., & Kurtz, A. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00988.x · Cited by 62 · see citing works

Gamma interferon stimulates monocyte chemotactic protein (MCP-1) in human mesangial cells.

Grandaliano, G., Valente, A. J., Rozek, M. M., & Abboud, H. E. (1994) · PubMed · Cited by 62 · see citing works

Cyclooxygenase metabolites mediate glomerular monocyte chemoattractant protein-1 formation and monocyte recruitment in experimental glomerulonephritis

Schneider, A., Harendza, S., Zahner, G., Jocks, T., Wenzel, U. O., Wolf, G., Thaiss, F., Helmchen, U. M., & Stahl, R. A. K. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00265.x · Cited by 61 · see citing works

Does Paracetamol Cause Urothelial Cancer or Renal Papillary Necrosis?

McCredie, M. R. E., & Stewart, J. H. (2008) · ˜The œNephron journals/Nephron journals · doi:10.1159/000185079 · Cited by 61 · see citing works

Expression and localization of cyclooxygenase isoforms and cytosolic phospholipase A2 in anti-Thy-1 glomerulonephritis.

Hirose, S., Yamamoto, T. S., Feng, L., Yaoita, E., Kawasaki, K., Goto, S., Fujinaka, H., Wilson, C. B., Arakawa, M., & Kihara, I. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93408 · Cited by 61 · see citing works

The pharmacological properties and clinical use of valdecoxib, a new cyclo‐oxygenase‐2‐selective inhibitor

Alsalameh, S., Burian, M., Mahr, G., Woodcock, B. G., & Geißlinger, G. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01460.x · Cited by 61 · see citing works

Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites

Bosch‐Marcé, M., Clària, J., Titos, E., Masferrer, J. L., Altuna, R., Poo, J., Jiménez, W., Arroyo, V., Rivera, F., & Rodés, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70020-x · Cited by 60 · see citing works

Nitric oxide regulates renal cortical cyclooxygenase-2 expression

Cheng, H., Wang, J.-L., Zhang, M., McKanna, J. A., & Harris, R. C. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.1.f122 · Cited by 60 · see citing works

Effects of Celecoxib and Diclofenac on Blood Pressure, Renal Function, and Vasoactive Prostanoids in Young and Elderly Subjects

Dilger, K., Herrlinger, C., Peters, J., Seyberth, H. W., Schweer, H., & Klotz, U. E. (2002) · The Journal of Clinical Pharmacology · doi:10.1177/009127000204200905 · Cited by 59 · see citing works

Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2

Kim, G., Choi, N. W., Jung, J., Song, J., Lee, C. H., Kang, C. M., & Knepper, M. A. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00366.2007 · Cited by 59 · see citing works

Treatment of congenital nephrogenic diabetes insipidus by hydrochlorothiazide and cyclooxygenase-2 inhibitor

Pattaragarn, A., & Alon, U. S. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1195-0 · Cited by 58 · see citing works

Indomethacin-induced renal damage: role of oxygen free radicals

Basivireddy, J., Jacob, M., Pulimood, A. B., & Balasubramanian, K. A. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.023 · Cited by 56 · see citing works

Renal and cardiovascular characterization of COX-2 knockdown mice

Seta, F., Chung, A. D., Turner, P. V., Mewburn, J. D., Yu, Y., & Funk, C. D. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90985.2008 · Cited by 55 · see citing works

Indomethacin reduces proteinuria in passive Heymann nephritis in rats

Zoja, C., Benigni, A., Verroust, P. J., Ronco, P. M., Bertani, T., & Remuzzi, G. (1987) · Kidney International · doi:10.1038/ki.1987.147 · Cited by 53 · see citing works

Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen

Whelton, A., Lefkowith, J. B., West, C. R., & Verburg, K. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001766 · Cited by 53 · see citing works

Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta

Rzymkiewicz, D. M., Leingang, K. A., Baird, N. R., & Morrison, A. R. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.266.1.f39 · Cited by 53 · see citing works

Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites

López‐Parra, M., Clària, J., Planagumà, A., Titos, E., Masferrer, J. L., Woerner, B. M., Koki, A. T., Jiménez, W., Altuna, R., Arroyo, V., et al. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704528 · Cited by 52 · see citing works

Deficiency of COX-1 causes natriuresis and enhanced sensitivity to ACE inhibition

Athirakul, K., Kim, H., Audoly, L., Smithies, O., & Coffman, T. M. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00072.x · Cited by 51 · see citing works

Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive Heymann nephritis in the rat

Blume, C. A., Heise, G., Mühlfeld, A., Bach, D., Schrör, K., Gerharz, C. D., Grabensee, B., & Heering, P. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00742.x · Cited by 50 · see citing works

Acute upregulation of COX-2 by renal artery stenosis

Mann, B., Hartner, A., Jensen, B. L., Hilgers, K. F., Höcherl, K., Krämer, B. K., & Kurtz, A. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.1.f119 · Cited by 50 · see citing works

Cyclooxygenase-2–Dependent Prostacyclin Formation and Blood Pressure Homeostasis

Yu, Y., Stubbe, J., Ibrahim, S. A., Song, W., Symth, E. M., Funk, C. D., & FitzGerald, G. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.204529 · Cited by 49 · see citing works

Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.

Packer, M. (1988) · PubMed · Cited by 48 · see citing works

Role of platelet activating factor in endotoxemic acute renal failure in the male rat.

Tolins, J. P., Vercellotti, G. M., Wilkowske, M., Ha, B., Jacob, H. S., & Raij, L. (1989) · PubMed · Cited by 48 · see citing works

Low sodium and furosemide‐induced stimulation of the renin system in man is mediated by cyclooxygenase 2

Kammerl, M., Nüsing, R. M., Schweda, F., Endemann, D., Stubanus, M., Kees, F., Lackner, K. J., Fischereder, M., & Krämer, B. K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)49789-x · Cited by 47 · see citing works

Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake

Höcherl, K., Kammerl, M., Schumacher, K., Endemann, D., Grobecker, H., & Kurtz, A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00347.2001 · Cited by 46 · see citing works

CYCLOOXYGENASE-2 INHIBITOR PRESERVES MEDULLARY AQUAPORIN-2 EXPRESSION AND PREVENTS POLYURIA AFTER URETERAL OBSTRUCTION

Cheng, X., Zhang, H., Lee, H.-L., & Park, J. M. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000143882.52960.ee · Cited by 45 · see citing works

Renal papillary necrosis induced by naproxen

Kovacevic, L. G., Bernstein, J., Valentini, R. P., Imam, A. A., Gupta, N., & Mattoo, T. K. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1167-4 · Cited by 45 · see citing works

Suppression of cytokine responses by indomethacin in podocytes: a mechanism through induction of unfolded protein response

Okamura, M., Takano, Y., Hiramatsu, N., Hayakawa, K., Yao, J. Q., Paton, A. W., Paton, J. C., & Kitamura, M. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00602.2007 · Cited by 45 · see citing works

Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus

Cherney, D. Z. I., Scholey, J. W., Nasrallah, R., Dekker, M. G., Slorach, C., Bradley, T. J., Hébert, R., Sochett, E. B., & Miller, J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00574.2007 · Cited by 44 · see citing works

Elevated Urinary Prostaglandin Excretion and the Effect of Indomethacin on Renal Function in Incipient Diabetic Nephropathy

Mathiesen, E. R., Hommel, E. E., Olsen, U. B., & Parving, H. ‐. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00961.x · Cited by 44 · see citing works

EXTENT OF RENAL EFFECT OF CYCLO‐OXYGENASE‐2‐SELECTIVE INHIBITORS IS PHARMACOKINETIC DEPENDENT

Harirforoosh, S., Aghazadeh‐Habashi, A., & Jamali, F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04464.x · Cited by 43 · see citing works

Renal papillary necrosis in juvenile rheumatoid arthritis

Wortmann, D. W., Kelsch, R. C., Kuhns, L. R., Sullivan, D. B., & Cassidy, J. T. (1980) · The Journal of Pediatrics · doi:10.1016/s0022-3476(80)80126-0 · Cited by 43 · see citing works

Acute Renal Failure Associated with Rofecoxib

Wolf, G., Porth, J., & Stahl, R. A. K. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-5-200009050-00024 · Cited by 43 · see citing works

Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1

Cheng, H., Wang, S.-W., Zhang, M., McKanna, J. A., BREYER, R. M., & Harris, R. C. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00150.2002 · Cited by 43 · see citing works

COX-2 activity determines the level of renin expression but is dispensable for acute upregulation of renin expression in rat kidneys

Matzdorf, C., Kurtz, A., & Höcherl, K. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00513.2006 · Cited by 43 · see citing works

Reactive Oxygen Species and Cyclooxygenase 2-Derived Thromboxane A2 Reduce Angiotensin II Type 2 Receptor Vasorelaxation in Diabetic Rat Resistance Arteries

Retailleau, K., de Chantemèle, E. J. B., Chanoine, S., Guihot, A., Vessières, E., Toutain, B., Faure, S., Bagi, Z. A., Loufrani, L., & Henrion, D. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.140236 · Cited by 42 · see citing works

Enhanced intrarenal angiotensin II generation in response to obstruction of the pig ureter

Frøkiær, J., Knudsen, L., Nielsen, A. S., Pedersen, E. B., & Djurhuus, J. C. (1992) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1992.263.3.f527 · Cited by 40 · see citing works

The macula densa is worth its salt

Schnermann, J. B., & Briggs, J. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8539 · Cited by 39 · see citing works

COX-2 activity transiently contributes to increased water and NaCl excretion in the polyuric phase after release of ureteral obstruction

Nørregaard, R., Jensen, B. L., Topcu, S. O., Diget, M., Schweer, H., Knepper, M. A., Nielsen, S. S., & Frøkiær, J. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00394.2006 · Cited by 39 · see citing works

COX-2 inhibition attenuates endotoxin-induced downregulation of organic anion transporters in the rat renal cortex

Höcherl, K., Schmidt, C. G., & Bucher, M. (2008) · Kidney International · doi:10.1038/ki.2008.557 · Cited by 39 · see citing works

Nephrotoxic Potential of Selective Cyclooxygenase-2 Inhibitors

Sandhu, G. K., & Heyneman, C. A. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d296 · Cited by 39 · see citing works

Novel Actions of Nonsteroidal Anti-Inflammatory Drugs on Vascular Ion Channels: Accounting for Cardiovascular Side Effects and Identifying New Therapeutic Applications.

Brueggemann, L. I., Mani, B. K., Mackie, A. R., Cribbs, L. L., & Byron, K. L. (2010) · PubMed · Cited by 38 · see citing works

Cyclooxygenase-2 contributes to elevated renin in the early postnatal period in rats

Stubbe, J., Jensen, B. L., Bachmann, S., Morsing, P., & Skøtt, O. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00340.2002 · Cited by 38 · see citing works

The Impact of Ibuprofen on the Efficacy of Antihypertensive Treatment With Hydrochlorothiazide in Elderly Persons

Gurwitz, J. H., Everitt, D. E., Monane, M., Glynn, R., Choodnovskiy, I., Beaudet, M., & Avorn, J. (1996) · The Journals of Gerontology Series A · doi:10.1093/gerona/51a.2.m74 · Cited by 38 · see citing works

Renal effects of cyclooxygenase-2 selective inhibitors

Harris, C. J., & Brater, D. C. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200109000-00009 · Cited by 37 · see citing works

Cyclo-Oxygenase-2 Inhibitors and the Kidney

Noroian, G., & Clive, D. M. (2002) · Drug Safety · doi:10.2165/00002018-200225030-00003 · Cited by 36 · see citing works

Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2–COX-1 selectivity on urinary sodium and potassium excretion in the rat

Harirforoosh, S., & Jamali, F. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-129 · Cited by 35 · see citing works

Interactions of the renin–angiotensin system and neuronal nitric oxide synthase in regulation of cyclooxygenase‐2 in the macula densa

Harris, Chêng, Wang, Zhang, & McKanna (2000) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2000.00642.x · Cited by 34 · see citing works

Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation

Zahner, G., Schaper, M., Panzer, U., Kluger, M. A., Stahl, R. A. K., Thaiss, F., & Schneider, A. (2009) · Biochemical Journal · doi:10.1042/bj20090420 · Cited by 34 · see citing works

Inhibition of Cyclooxygenases Reduces Complement-Induced Glomerular Epithelial Cell Injury and Proteinuria in Passive Heymann Nephritis

Takano, T., Cybulsky, A. V., Cupples, W. A., Ajikobi, D. O., Papillon, J., & Aoudjit, L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043604 · Cited by 33 · see citing works

ACUTE RENAL PAPILLARY NECROSIS INDUCED BY IBUPROFEN

Atta, M. G., & Whelton, A. (1997) · American Journal of Therapeutics · doi:10.1097/00045391-199701000-00011 · Cited by 33 · see citing works

Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis.

Landewé, R., Thè, H. S. G., van Rijthoven, A. W. A. M., Rietveld, J. R., Breedveld, F. C., & Dijkmans, B. A. C. (1994) · PubMed · Cited by 33 · see citing works

Practical considerations for the use of nonsteroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors in hypertension and kidney disease.

LeLorier, J., Bombardier, C., Burgess, E. D., MOIST, L. M., Wright, N., Cartier, P., Huckell, V. F., Hunt, R., Nawar, T., & Tobe, S. W. (2002) · PubMed · Cited by 32 · see citing works

Interactions between 11β-hydroxysteroid dehydrogenase and COX-2 in kidney

Yao, B., Harris, R. C., & Zhang, M. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00786.2004 · Cited by 32 · see citing works

Prostaglandin E1 reduces the glomerular mRNA expression of monocyte-chemoattractant protein 1 in anti-thymocyte antibody-induced glomerular injury.

Jocks, T., Zahner, G., Freudenberg, J., Wolf, G., Thaiss, F., Helmchen, U. M., & Stahl, R. A. K. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v76897 · Cited by 32 · see citing works

Urinary tract obstruction induces transient accumulation of COX-2-derived prostanoids in kidney tissue

Nørregaard, R., Jensen, B. L., Topcu, S. O., Wang, G., Schweer, H., Nielsen, S. D.-H., & Frøkiær, J. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00336.2009 · Cited by 31 · see citing works

Chronic COX Inhibition Reduces Diabetes-Induced Hyperfiltration, Proteinuria, and Renal Pathological Markers in 36-Week B6-Ins2Akita Mice

Nasrallah, R., Robertson, S. J., & Hébert, R. (2009) · American Journal of Nephrology · doi:10.1159/000229304 · Cited by 30 · see citing works

Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression

Höcherl, K., Kees, F., Krämer, B. K., & Kurtz, A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00627.x · Cited by 30 · see citing works

Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study

Guevara, M., Abecasis, R., & Terg, R. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520310008205 · Cited by 29 · see citing works

Prostaglandin E1 suppresses macrophage infiltration and ameliorates injury in an experimental model of macrophage-dependent glomerulonephritis

Cattell, V., Smith, J., & Cook, H. T. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb05188.x · Cited by 29 · see citing works

Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis*1, *2

ROS, J. (1995) · Hepatology · doi:10.1016/0270-9139(95)90315-1 · Cited by 29 · see citing works

INDOMETHACIN-INDUCED RENAL PAPILLARY NECROSIS IN JUVENILE CHRONIC ARTHRITIS

Mitchell, H. E., Muirden, K. D., & Kincaid‐Smith, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90638-9 · Cited by 28 · see citing works

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153 · see citing works

Oxidative Stress and Inflammation in Osteoarthritis Pathogenesis: Role of Polyphenols

Ansari, M. Y., Ahmad, N., & Haqqi, T. (2020) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2020.110452 · Cited by 665 · see citing works

Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview

Mignani, S. M., Kazzouli, S. E., Bousmina, M., & Majoral, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.01.001 · Cited by 335 · see citing works

Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs

Lucas, G. N. C., Leitão, A. C. C., Alencar, R. L., Xavier, R. M. F., Daher, E. D. F., & da Silva, G. B. (2018) · Brazilian Journal of Nephrology · doi:10.1590/2175-8239-jbn-2018-0107 · Cited by 310 · see citing works

Pathological mechanisms and therapeutic outlooks for arthrofibrosis

Usher, K. M., Zhu, S., Mavropalias, G., Carrino, J. A., Zhao, J., & Xu, J. (2019) · Bone Research · doi:10.1038/s41413-019-0047-x · Cited by 291 · see citing works

Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level

Günaydın, C., & Bilge, S. S. (2018) · Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2018.0010 · Cited by 287 · see citing works

Kidney damage from nonsteroidal anti‐inflammatory drugs—Myth or truth? Review of selected literature

Drożdżal, S., Lechowicz, K., Szostak, B., Rosik, J., Kotfis, K., Machoy‐Mokrzyńska, A., Białecka, M. A., Ciechanowski, K., & Gawronska-Szklarz, B. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.817 · Cited by 157 · see citing works

Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations

Szeto, C., Sugano, K., Wang, J., Fujimoto, K., Whittle, S., Modi, G. K., Chen, C.-H., Park, J.-B., Tam, L., Vareesangthip, K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319300 · Cited by 158 · see citing works

Spinal Manipulative Therapy and Other Conservative Treatments for Low Back Pain: A Guideline From the Canadian Chiropractic Guideline Initiative

Bussières, A., Stewart, G., Zoubi, F. A., Decina, P., Descarreaux, M., Haskett, D., Hincapié, C. A., Pagé, I., Passmore, S. R., Srbely, J. Z., et al. (2018) · Journal of Manipulative and Physiological Therapeutics · doi:10.1016/j.jmpt.2017.12.004 · Cited by 149 · see citing works

Therapeutic role of nitric oxide as emerging molecule

Kumar, S., Singh, R. K., & Bhardwaj, T. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.11.125 · Cited by 116 · see citing works

Different Chemical Structures and Physiological/Pathological Roles of Cyclooxygenases

Faki, Y., & Er, A. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10426 · Cited by 115 · see citing works

Overview on the Discovery and Development of Anti-Inflammatory Drugs: Should the Focus Be on Synthesis or Degradation of PGE2?

Mahesh, G., Kumar, K. A., & Reddanna, P. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s278514 · Cited by 112 · see citing works

Duration of Symptom Relief and Early Trajectory of Adverse Events for Oral Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis: A Systematic Review and Meta‐Analysis

Osani, M. C., Vaysbrot, E. E., Zhou, M., McAlindon, T. E., & Bannuru, R. R. (2019) · Arthritis Care & Research · doi:10.1002/acr.23884 · Cited by 105 · see citing works

Evaluation of anti-inflammatory activity of selected medicinal plants used in Indian traditional medication system in vitro as well as in vivo

Shaikh, R. U., Pund, M., & Gacche, R. N. (2015) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2015.07.001 · Cited by 104 · see citing works

Renal co-morbidity in patients with rheumatic diseases

Anders, H., & Vielhauer, V. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3256 · Cited by 96 · see citing works

Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55

Alba, R. G., Barragán‐Iglesias, P., González‐Hernández, A., Valdez-Moráles, E. E., Granados‐Soto, V., Condés‐Lara, M., Rodríguez, M. G., & Marichal‐Cancino, B. A. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01496 · Cited by 94 · see citing works

Cardiac Surgery–Associated Acute Kidney Injury

Scurt, F. G., Bose, K., Mertens, P. R., Chatzikyrkou, C., & Herzog, C. (2024) · Kidney360 · doi:10.34067/kid.0000000000000466 · Cited by 93 · see citing works

Design, classification, and adverse effects of NSAIDs: A review on recent advancements

Arfeen, M., Srivastava, A., Srivastava, N., Khan, R. A., Almahmoud, S. A., & Mohammed, H. A. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117899 · Cited by 92 · see citing works

Acute Kidney Injury After Cardiac Surgery: A Narrative Review of the Literature

Chew, S. T. H., & Hwang, N. C. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.08.003 · Cited by 90 · see citing works

Medication-Induced Interstitial Nephritis in the 21st Century

Nast, C. C. (2017) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2016.11.016 · Cited by 88 · see citing works

Indomethacin impairs mitochondrial dynamics by activating the PKCζ–p38–DRP1 pathway and inducing apoptosis in gastric cancer and normal mucosal cells

Mazumder, S., De, R., Debsharma, S., Bindu, S., Maity, P., Sarkar, S., Saha, S. J., Siddiqui, A. A., Banerjee, C., Nag, S., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004415 · Cited by 91 · see citing works

Cyclooxygenase 2: protein-protein interactions and posttranslational modifications

Alexanian, A., & Sorokin, A. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00086.2017 · Cited by 84 · see citing works

Malaria-Associated Acute Kidney Injury in African Children: Prevalence, Pathophysiology, Impact, and Management Challenges

Batte, A., Berrens, Z. J., Murphy, K. J., Mufumba, I., Sarangam, M. L., Hawkes, M., & Conroy, A. L. (2021) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s239157 · Cited by 84 · see citing works

Non-steroidal anti-inflammatory drug effects on renal and cardiovascular function: from physiology to clinical practice

Cabassi, A., Tedeschi, S., Perlini, S., Verzicco, I., Volpi, R., Gonzi, G., & Canale, S. D. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319848105 · Cited by 81 · see citing works

Protective effects of curcumin against naproxen-induced mitochondrial dysfunction in rat kidney tissue

Aziziaram, Z., Bilal, I., Zhong, Y., Mahmod, A. K., & Roshandel, R. (2021) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2021.138879.1001 · Cited by 77 · see citing works

Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury: a narrative review

Yu, Y., Li, C., Zhu, S., Jin, L., Hu, Y. W., Ling, X., Miao, C., & Guo, K. (2023) · European journal of medical research · doi:10.1186/s40001-023-00990-2 · Cited by 76 · see citing works

Association of Nonsteroidal Anti-inflammatory Drug Prescriptions With Kidney Disease Among Active Young and Middle-aged Adults

Nelson, D. A., Marks, E. S., Deuster, P. A., O’Connor, F. G., & Kurina, L. M. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7896 · Cited by 74 · see citing works

Mechanisms of triple whammy acute kidney injury

Prieto-García, L., Pericacho, M., Sancho‐Martínez, S. M., Sánchez, Á., Martínez‐Salgado, C., López-Novoa, J. M., & López-Hernández, F. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.011 · Cited by 75 · see citing works

Renal Manifestations of Rheumatoid Arthritis

Kapoor, T. M., & Bathon, J. M. (2018) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2018.06.008 · Cited by 65 · see citing works

Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden

Peterson, C., & Gustafsson, M. V. (2017) · Drugs - Real World Outcomes · doi:10.1007/s40801-017-0108-7 · Cited by 61 · see citing works

Photoactivation of peroxymonosulfate by wood pulp cellulose biochar/g-C3N4 composite for diclofenac degradation: the radical and nonradical pathways

Han, Y. J., Gan, L., Gong, H., Han, J., Qiao, W., & Xu, L. (2022) · Biochar · doi:10.1007/s42773-022-00155-0 · Cited by 59 · see citing works

Non-steroidal anti-inflammatory drugs among chronic kidney disease patients: an epidemiological study

ElHafeez, S. A., Hegazy, R., Naga, Y. S., Wahdan, I. H., & Sallam, S. (2019) · Journal of the Egyptian Public Health Association · doi:10.1186/s42506-018-0005-2 · Cited by 51 · see citing works

The modulatory effect of Moringa oleifera leaf extract on endogenous antioxidant systems and inflammatory markers in an acetaminophen-induced nephrotoxic mice model

Karthivashan, G., Kura, A. U., Arulselvan, P., Isa, N. M., & Fakurazi, S. (2016) · PeerJ · doi:10.7717/peerj.2127 · Cited by 51 · see citing works

The effects of single‐dose dexamethasone on inflammatory response and pain after uterine artery embolisation for symptomatic fibroids or adenomyosis: a randomised controlled study

Kim, S., Koo, B., Shin, C. S., Ban, M. G., Han, K., & Kim, M. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13785 · Cited by 50 · see citing works

In Silico Prediction and Insights Into the Structural Basis of Drug Induced Nephrotoxicity

Shi, Y., Hua, Y., Wang, B., Zhang, R., & Li, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.793332 · Cited by 48 · see citing works

Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease

Sidhom, E.-H., Kim, C., Kost‐Alimova, M., Ting, M. T., Keller, K. H., Ávila-Pacheco, J., Watts, A. J. B., Vernon, K. A., Marshall, J. L., Bricio, E. R., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141380 · Cited by 48 · see citing works

Galangin’s potential as a functional food ingredient

Mak, K., Tan, J.-J., Marappan, P., Balijepalli, M. K., Choudhury, H., Ramamurthy, S., & Pichika, M. R. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.04.054 · Cited by 46 · see citing works

Systematic review and meta‐analysis on non‐opioid analgesics in palliative medicine

Schüchen, R. H., Mücke, M., Marinova, M., Kravchenko, D., Häuser, W., Radbruch, L., & Conrad, R. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12352 · Cited by 45 · see citing works

A Review on Drug‐Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches

Mody, H. R., Ramakrishnan, V., Chaar, M., Lezeau, J., Rump, A., Taha, K., Lesko, L. J., & Ait‐Oudhia, S. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.879 · Cited by 45 · see citing works

The molecular mechanisms of celecoxib in tumor development

Wen, B., Wei, Y., Mu, L.-L., Wen, G., & Zhao, K. (2020) · Medicine · doi:10.1097/md.0000000000022544 · Cited by 44 · see citing works

Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors

Murahari, M., Mahajan, V., Neeladri, S., Kumar, M. S., & Mayur, Y. C. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.02.031 · Cited by 41 · see citing works

Reconnoitering the Therapeutic Role of Curcumin in Disease Prevention and Treatment: Lessons Learnt and Future Directions

Sivani, B. M., Azzeh, M., Patnaik, R., Stoian, A. P., Rizzo, M., & Banerjee, Y. (2022) · Metabolites · doi:10.3390/metabo12070639 · Cited by 41 · see citing works

Madecassoside activates anti‑neuroinflammatory mechanisms by inhibiting lipopolysaccharide‑induced microglial inflammation

Sasmita, A. O., Ling, A. P. K., Voon, K., Koh, R. Y., & Wong, Y. P. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3479 · Cited by 41 · see citing works

Frequency and Associations of Prescription Nonsteroidal Anti-inflammatory Drug Use Among Patients With a Musculoskeletal Disorder and Hypertension, Heart Failure, or Chronic Kidney Disease

Bouck, Z., Mecredy, G. C., Ivers, N. M., Barua, M., Martin, D., Austin, P. C., Tepper, J. D., & Bhatia, R. S. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.4273 · Cited by 40 · see citing works

Comparative Risks of Nonsteroidal Anti-Inflammatory Drugs on CKD

Wan, E. Y. F., Yu, E. Y. T., Chan, L. S., Mok, A. H. Y., Wang, Y., Chan, E. W., Wong, I. C. K., & Lam, C. L. K. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.18501120 · Cited by 40 · see citing works

A Randomized, Double Blind, Placebo Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Curene® versus Placebo in Reducing Symptoms of Knee OA

Panda, S. K., Nirvanashetty, S., Parachur, V. A., Mohanty, N., & Swain, T. (2018) · BioMed Research International · doi:10.1155/2018/5291945 · Cited by 38 · see citing works

Advances in Ultra-small Fluorescence Nanoprobes for Detection of Metal Ions, Drugs, Pesticides and Biomarkers

Kateshiya, M. R., Desai, M. L., Malek, N. I., & Kailasa, S. K. (2022) · Journal of Fluorescence · doi:10.1007/s10895-022-03115-w · Cited by 37 · see citing works

Design and synthesis of some pyrazole derivatives of expected anti-inflammatory and analgesic activities

Gawad, N. M. A., Hassan, G. S., & Georgey, H. H. (2011) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9606-4 · Cited by 36 · see citing works

Risk of Kidney Dysfunction from Polypharmacy among Older Patients: A Nested Case-Control Study of the South Korean Senior Cohort

Kang, H., & Hong, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-46849-7 · Cited by 36 · see citing works

Dose-dependent pro- or anti-fibrotic responses of endometriotic stromal cells to interleukin-1β and tumor necrosis factor α

Matsuzaki, S., Pouly, J. L., & Canis, M. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-66298-x · Cited by 33 · see citing works

Application of AP-MALDI Imaging Mass Microscope for the Rapid Mapping of Imipramine, Chloroquine, and Their Metabolites in the Kidney and Brain of Wild-Type Mice

Islam, A., Sakamoto, T., Zhai, Q., Rahman, M. M., Mamun, M. A., Takahashi, Y., Kahyo, T., & Setou, M. (2022) · Pharmaceuticals · doi:10.3390/ph15111314 · Cited by 33 · see citing works

Contrast Induced Acute Kidney Injury and Direct Cytotoxicity of Iodinated Radiocontrast Media on Renal Proximal Tubule Cells

Ward, D. B., & Valentovic, M. A. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257337 · Cited by 32 · see citing works

Discovery of new non-acidic lonazolac analogues with COX-2 selectivity as potent anti-inflammatory agents

Harras, M. F., Sabour, R., & Kamaly, O. M. A. (2019) · MedChemComm · doi:10.1039/c9md00228f · Cited by 32 · see citing works

Renal mitochondrial restoration by gymnemic acid in gentamicin-mediated experimental nephrotoxicity: evidence from serum, kidney and histopathological alterations

Gumbar, S., Bhardwaj, S., Mehan, S., Khan, Z., Narula, A. S., Kalfin, R. E., Tabrez, S. S. M., Zughaibi, T. A., & Wasi, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1218506 · Cited by 30 · see citing works

Burden of Renal Events Associated with Nonsteroidal Anti-inflammatory Drugs in Patients with Osteoarthritis and Chronic Low Back Pain: A Retrospective Database Study

Katsuno, T., Togo, K., Ebata, N., Fujii, K., Yonemoto, N., Abraham, L., & Kikuchi, S. (2021) · Pain and Therapy · doi:10.1007/s40122-020-00233-w · Cited by 29 · see citing works

Physiological and pathophysiological implications of PGE2 and the PGE2 synthases in the kidney

Wang, J., Liu, M., Zhang, X., Yang, G., & Chen, L. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.10.006 · Cited by 27 · see citing works

The Application of Humane Endpoints and Humane Killing Methods in Animal Research Proposals: A Retrospective Review

Herrmann, K., & Flecknell, P. A. (2018) · Alternatives to Laboratory Animals · doi:10.1177/026119291804600606 · Cited by 27 · see citing works

Euphorbia neriifolia (Indian Spurge Tree): A Plant of Multiple Biological and Pharmacological Activities

Chaudhary, P., Singh, D., Swapnil, P., Meena, M., & Janmeda, P. (2023) · Sustainability · doi:10.3390/su15021225 · Cited by 29 · see citing works

Design, synthesis and biological evaluation of new imidazo[1,2-a]pyridine derivatives as selective COX-2 inhibitors

Ismael, A. S., Amin, N. H., El‐Saadi, M. T., Ali, M. R. A., & Abdel-Rahman, H. M. (2021) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2021.131652 · Cited by 26 · see citing works

Analgesic use and associated adverse events in patients with chronic kidney disease: a systematic review and meta-analysis

Lambourg, E. J., Colvin, L., Guthrie, G. D., Walker, H., & Bell, S. (2021) · British Journal of Anaesthesia · doi:10.1016/j.bja.2021.08.035 · Cited by 26 · see citing works

Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence

Broughton‐Neiswanger, L. E., Rivera, S. M., Suarez, M. A., Slovak, J. E., Piñeyro, P. E., Hwang, J. K., & Villarino, N. F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0228989 · Cited by 22 · see citing works

Mechanochemical prepared ibuprofen- Polygonatum sibiricum polysaccharide drug delivery system for enhanced bioactivity with reduced renal injury induced by NSAIDs

Xu, W., Yang, J., Gu, X., Su, W., Pu, F., Xie, Z., Jin, K., Su, W., & Mao, L. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2026533 · Cited by 24 · see citing works

Biological detoxification of mycotoxins: Emphasizing the role of algae

Yadavalli, R., Valluru, P., Raj, R., Reddy, C. N., & Mishra, B. (2023) · Algal Research · doi:10.1016/j.algal.2023.103039 · Cited by 24 · see citing works

Induction of mitochondrial toxicity by non-steroidal anti-inflammatory drugs (NSAIDs): The ultimate trade-off governing the therapeutic merits and demerits of these wonder drugs

Mazumder, S., Bindu, S., Debsharma, S., & Bandyopadhyay, U. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116283 · Cited by 23 · see citing works

Mast cells and pro-inflammatory cytokines roles in assessment of grape seeds extract anti-inflammatory activity in rat model of carrageenan-induced paw edema.

Abdallah, A. A. M., El-Deen, N. A. M. N., Mohamed, W. A. M., & Naguib, F. M. (2018) · PubMed Central · doi:10.22038/ijbms.2017.25067.6219 · Cited by 23 · see citing works

Diclofenac attenuates inflammation through TLR4 pathway and improves exercise performance after exhaustive swimming

Steckling, F. M., Lima, F. D., Farinha, J. B., da Rosa, P. C., Royes, L. F. F., Cuevas, M. J., Bresciani, G., Soares, F. A. A., González‐Gallego, J., & Barcelos, R. P. (2019) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13579 · Cited by 22 · see citing works

Phytochemical Analysis by HPLC–HRESI-MS and Anti-Inflammatory Activity of Tabernaemontana catharinensis

Marques, J. I., Alves, J. S. F., Torres-Rêgo, M., Furtado, A. A., Siqueira, E. M. S., Galinari, É., Araújo, D. F. D. S., Guerra, G. C. B., de Azevedo, E. P., Fernandes‐Pedrosa, M. D. F., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020636 · Cited by 22 · see citing works

Creatinine-Based Renal Function Estimates and Dosage of Postoperative Pain Management for Elderly Acute Hip Fracture Patients

Houlind, M. B., Petersen, K. K., Palm, H., Jørgensen, L. M., Aakjær, M., Christrup, L. L., Petersen, J., Andersen, O., & Treldal, C. (2018) · Pharmaceuticals · doi:10.3390/ph11030088 · Cited by 21 · see citing works

Non-Steroidal Anti-Inflammatory Drugs and Risk of Acute Kidney Injury and Hyperkalemia in Older Adults: A Retrospective Cohort Study and External Validation of a Clinical Risk Model

Lim, C. C., Tan, N. C., Teo, P. S. E., Kadir, H. B. A., Kwek, J. L., Bee, Y. M., Ang, A. T. W., Teo, S. H., Kaushik, M., Tan, C. S., et al. (2021) · Drugs & Aging · doi:10.1007/s40266-021-00907-w · Cited by 21 · see citing works

Short-Course Systemic and Topical Non-Steroidal Anti-Inflammatory Drugs: Impact on Adverse Renal Events in Older Adults with Co-Morbid Disease

Lim, C. C., Ang, A. T. W., Kadir, H. B. A., Lee, P. H., Goh, B. Q., Harikrishnan, S., Kwek, J. L., Gan, S. S. W., Choo, J. C. J., & Tan, N. C. (2020) · Drugs & Aging · doi:10.1007/s40266-020-00824-4 · Cited by 21 · see citing works

Angiotensin II receptor blockade alleviates calcineurin inhibitor nephrotoxicity by restoring cyclooxygenase 2 expression in kidney cortex

Hu, J., Xu, Y., Bachmann, S., & Mutig, K. (2020) · Acta Physiologica · doi:10.1111/apha.13612 · Cited by 20 · see citing works

Characterization of human sulfotransferases catalyzing the formation of p-cresol sulfate and identification of mefenamic acid as a potent metabolism inhibitor and potential therapeutic agent for detoxification

Rong, Y., & Kiang, T. K. L. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115553 · Cited by 20 · see citing works

Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation

Menon, R., Bomback, A. S., Lake, B. B., Stutzke, C., Grewenow, S. M., Menez, S. P., D’Agati, V. D., Jain, S. R., Knight, R., Lecker, S. H., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.03.011 · Cited by 20 · see citing works

Bi2MoO6 nanofilms on the stainless steel mesh by PS-PED method: Photocatalytic degradation of diclofenac sodium as a pharmaceutical pollutant

Zargazi, M., & Entezari, M. H. (2019) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2019.104867 · Cited by 20 · see citing works

Localization of prostaglandin E2 synthases and E-prostanoid receptors in the spinal cord in a rat model of neuropathic pain

Kanda, H., Kobayashi, K., Yamanaka, H., Okubo, M., Dai, Y., & Noguchi, K. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147153 · Cited by 19 · see citing works

Bodybuilding: A Comprehensive Review of Performance-Enhancing Substance Use and Public Health Implications

Mantri, S., Agarwal, S., Jaiswal, A., Yelne, S., Prasad, R., & Wanjari, M. B. (2023) · Cureus · doi:10.7759/cureus.41600 · Cited by 19 · see citing works

A single dose of ketoprofen in the immediate postpartum period has the potential to improve dairy calf welfare in the first 48 h of life

Gladden, N., Ellis, K. A., Martin, J., Viora, L., & McKeegan, D. E. F. (2019) · Applied Animal Behaviour Science · doi:10.1016/j.applanim.2019.01.007 · Cited by 18 · see citing works

Cyclooxygenase 2 inhibition slows disease progression and improves the altered renal lipid mediator profile in the Pkd2WS25/− mouse model of autosomal dominant polycystic kidney disease

Monirujjaman, M., & Aukema, H. M. (2019) · Journal of Nephrology · doi:10.1007/s40620-018-00578-8 · Cited by 18 · see citing works

NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection

Cure, M. C., Küçük, A., & Cüre, E. (2020) · Therapies · doi:10.1016/j.therap.2020.06.012 · Cited by 18 · see citing works

Effects of resveratrol on biochemical and structural outcomes in osteoarthritis: A systematic review and meta-analysis of preclinical studies

Zhao, W., Zhu, Y., Wong, S. K., Muhammad, N., Pang, K.-L., & Chin, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34064 · Cited by 17 · see citing works

Pharmacokinetic profiles of meloxicam after single IV and PO administration in Bilgorajska geese

Sartini, I., Łebkowska‐Wieruszewska, B., Lisowski, A., Poapolathep, A., Owen, H. C., & Gıorgı, M. (2019) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12817 · Cited by 17 · see citing works

Effect of dose on the intravenous pharmacokinetics of tolfenamic acid in goats

Tekeli, İ. O., Türk, E., Çorum, D. D., Çorum, O., Kirgiz, F. C., & Üney, K. (2020) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12898 · Cited by 17 · see citing works

Haematological and biochemical studies on the effect of diclofenac sodium on Wistar Rattus norvegicus

Orinya, O. A., Adenkola, A. Y., & Ogbe, R. J. (2017) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v10i5.23 · Cited by 17 · see citing works

Special consideration for pain management in the older person

Ong, T. I. W., & Thiam, C. N. (2022) · Clinical Medicine · doi:10.7861/clinmed.cm-2022-0273 · Cited by 16 · see citing works

Selenocoxib-3, a novel anti-inflammatory therapeutic effectively resolves colitis

Kaur, R., Desai, D. H., Amin, S., Raza, K., Bhalla, A., Yadav, P., & Kaushal, N. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04532-y · Cited by 16 · see citing works

Potentially inappropriate concomitant medicine use with the selective COX-2 inhibitor celecoxib: Analysis and comparison of spontaneous adverse event reports from Australia, Canada and the USA.

Baselyous, Y., Cocinis, M. D., Ibrahim, M. Y., Kalra, A., Yacoub, R., & Ahmed, R. A. (2019) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2019.1589447 · Cited by 16 · see citing works

Euryops arabicus displays anti-inflammatory activities in experimental models

Abdel‐Lateff, A., Alarif, W. M., Algandaby, M. M., Alburae, N. A., & Abdel‐Naim, A. B. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112278 · Cited by 16 · see citing works

Indomethacin: Can It Counteract Bradykinin Effects in COVID-19 Patients?

Alkotaji, M. M., & Al-Zidan, R. N. (2021) · Current Pharmacology Reports · doi:10.1007/s40495-021-00257-6 · Cited by 16 · see citing works

Diclofenac-Induced Kidney Damage in Wistar Rats: Involvement of Antioxidant Mechanism

Abiola, T. S., Adebayo, O. C., & Babalola, O. O. (2019) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2019.712005 · Cited by 16 · see citing works

Ultra-small pyomelanin nanogranules abiotically derived from bacteria-secreted homogentisic acid show potential applications in inflammation and cancer

Narayanan, S., Kurian, N. K., & Bhat, S. G. (2019) · BioNanoScience · doi:10.1007/s12668-019-00689-x · Cited by 17 · see citing works

Association of Non‐Steroidal Anti‐Inflammatory Drugs with Kidney Health in Ambulatory Older Adults

Amatruda, J. G., Katz, R., Peralta, C. A., Estrella, M. M., Sarathy, H., Fried, L. F., Newman, A. B., Parikh, C. R., Ix, J. H., Sarnak, M. J., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16961 · Cited by 16 · see citing works

Impact of Intravenous Acetaminophen on Lengths of Stay and Discharge Status after Total Knee Arthroplasty

Barrington, J. W., Hansen, R. N., Lovelace, B., Boing, E., Chughtai, M., Newman, J. M., Pham, A., Khlopas, A., Sodhi, N., Sultan, A. A., et al. (2018) · The Journal of Knee Surgery · doi:10.1055/s-0038-1636908 · Cited by 15 · see citing works

Risk Factors for End-Stage Renal Failure Among Patients on Hemodialysis in Aljomhory Hospital, Sa’adah Governorate, Yemen: Hospital-Based Case-Control Study

Dahnan, M., Assabri, A. M., & Khader, Y. S. (2019) · JMIR Public Health and Surveillance · doi:10.2196/14215 · Cited by 15 · see citing works

Influences of tolfenamic acid and flunixin meglumine on the disposition kinetics of levofloxacin in sheep

Çorum, D. D., Çorum, O., Yıldız, R., Faki, H. E., İder, M., Çetin, G., & Üney, K. (2020) · Acta Veterinaria Hungarica · doi:10.1556/004.2020.00015 · Cited by 15 · see citing works

Perioperative pharmacokinetics and pharmacodynamics of meloxicam in emus (Dromaius novaehollandiae) of different age groups using nonlinear mixed effect modelling

Castiñeiras, D., Armitage, L., Lamas, L. P., Baere, S. D., Croubels, S., & Pelligand, L. (2020) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12923 · Cited by 15 · see citing works

The aqueous extract of Glycyrrhiza glabra effectively prevents induced gastroduodenal ulcers: experimental study on Wistar rats

Goorani, S., Zhaleh, M., Zangeneh, A., Koohi, M. K., Rashidi, K., Moradi, R., & Zangeneh, M. M. (2018) · Comparative Clinical Pathology · doi:10.1007/s00580-018-2852-9 · Cited by 15 · see citing works

A critical review of adverse effects to the kidney: mechanisms, data sources, and in silico tools to assist prediction

Pletz, J., Enoch, S. J., Jais, D. M., Mellor, C. L., Pawar, G. V., Firman, J. W., Madden, J. C., Webb, S. D., Tagliati, C. A., & Cronin, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1539076 · Cited by 14 · see citing works

Nephrotic Syndrome and Acute Tubular Necrosis Due to Meloxicam Use

Vega, J. E., Helmuth Goecke, S., Méndez, G. P., & Guarda, F. J. (2012) · Renal Failure · doi:10.3109/0886022x.2012.718953 · Cited by 14 · see citing works

Prescribing patterns of non-steroidal anti-inflammatory drugs in chronic kidney disease patients in the South African private sector

Meuwesen, W. P., du Plessis, J. M., Burger, J. R., Lubbe, M. S., & Cockeran, M. (2016) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-016-0298-1 · Cited by 14 · see citing works

RENAL EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: A LITERATURE REVIEW

de Moraes, P. P., Azzi, T. B., da Conceição, A. C. A., Mattos, A. C. M., Costa, K. M., Rangel, M. A. N. A., Neto, R. J. D. F., Rocha, A. C. D. A. S. D. C., de Moraes, T. P., Lopes, P. D. A. C., et al. (2022) · International Journal of Health Science · doi:10.22533/at.ed.1592212220042

Anti-Inflammatory Drugs and the Kidney

House, A. A., Oliveira, S. S., & Ronco, C. (2007) · The International Journal of Artificial Organs · doi:10.1177/039139880703001203 · Cited by 25 · see citing works

Renal Effects of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors

Cheng, C. H. K., & Harris, R. C. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764922 · Cited by 136 · see citing works

COX-2 and the Kidney

Harris, R. C. (2006) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200605001-00007 · Cited by 139 · see citing works

The Renal Effects of Traditional Nonsteroidal Anti-Inflammatory Agents Versus Cyclooxygenase-2 Inhibitors

Joy, M. S. (2002) · Journal of Pharmacy Practice · doi:10.1177/089719002237254